The evolving landscape of immune‐related adverse events that follow immune checkpoint immunotherapy in cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The evolving landscape of immune‐related adverse events that follow immune checkpoint immunotherapy in cancer patients

Published:2023-08-26 Issue:1 Volume:318 Page:4-10
ISSN:0105-2896
Container-title:Immunological Reviews
language:en
Short-container-title:Immunological Reviews

Author:

Villani Alexandra‐Chloé¹²³⁴

Affiliation:

1. Center for Immunology and Inflammatory Diseases Department of Medicine Massachusetts General Hospital Massachusetts Boston USA

2. Mass General Cancer Center, Center for Cancer Research Massachusetts General Hospital Massachusetts Boston USA

3. Broad Institute of Massachusetts Institute of Technology and Harvard Massachusetts Cambridge USA

4. Harvard Medical School Massachusetts Boston USA

Funder

Massachusetts General Hospital

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imr.13270

Reference65 articles.

1. Cancer immunotherapy using checkpoint blockade

2. The diverse functions of the PD1 inhibitory pathway

3. CTLA-4 and PD-1 Pathways

4. PD-1 and Its Ligands in Tolerance and Immunity

5. CTLA-4 can function as a negative regulator of T cell activation

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP